Giada Lavigna

Check out this article just published in @NatureComms Prion protein promotes copper toxicity in Wilson disease. Great teamwork with Roman Polishchuk @Tigem_Telethon @prionicus @MarioNegriIRCCS nature.com/articles/s4146…

Proud to share our most recent work! @roberchiesa @MarioNegriIRCCS Give it a read! journals.plos.org/plosone/articl…

Insonnia Fatale: sabato 14 settembre la pedalata benefica "2000 km for Prion Research" dell’associazione Afiff farà tappa all’Istituto Mario Negri | Mario Negri marionegri.it/magazine/inson…

Peer reviewed @ReviewCommons version of the @GiadaLavigna et al. preprint now online. Trazodone, dibenzoylmethane and tauroursodeoxycholic acid do not prevent motor dysfunction and neurodegeneration in Marinesco-Sjögren syndrome mice biorxiv.org/content/10.110…

Congratulations to @GiadaLavigna and the team for their work evaluating partial PERK inhibitors and TUDCA in Marinesco-Sjögren syndrome mice!

Trazodone, dibenzoylmethane and tauroursodeoxycholic acid do not prevent motor dysfunction and neurodegeneration in ... biorxiv.org/cgi/content/sh… #biorxiv_pharma

👨‍🔬 Meet Jan Bieschke from @MRC_Prion , who will talk in the dedicated section of Prion Structure and Biology. 💥 Don't miss this opportunity, see you in Santiago! #IberianPrion2024 #Science #Santiagodecompostela #Scientificconference #ScientificExchange #prion #priondiseases

‼Are you coming to Santiago by train? Don’t miss this special discount from Renfe, to get it follow the instructions on our webpage! 🚂 Don’t miss this opportunity! Can’t wait to see you in Santiago! @Renfe #IberianPrion2024 #Scientificconference

📢 It's a pleasure to announce the distinguished speakers for the twelfth edition of the Iberian Prion 2024 conference. 🗣️ Our esteemed guests include: 1. 𝑱𝒂𝒏 𝑩𝒊𝒆𝒔𝒄𝒉𝒌𝒆 2. 𝑨𝒍𝒊𝒄𝒊𝒂 𝑶𝒕𝒆𝒓𝒐 3. 𝑰𝒏𝒈𝒂 𝒁𝒆𝒓𝒓 #IberianPrion2024 #Scientificconference

Embark on a journey with multiple transportation options at your disposal: ✈ By Airplane 🚄 By Train 🚌 By Bus 📍 Conference Venue: Rúa de San Francisco, s/n, 15782 Santiago de Compostela, A Coruña. 🌐 Coordinates - 42.88268818681163, -8.545600960415635 #IberianPrion2024

📣 Registrations are now open📣 On our website: iberianprion.org/2024/ under the Registration section, you can sign up for the twelfth edition of the Iberian Prion Conference. Don’t miss out!

🇪🇸 The 12th edition of Iberian Prion Conference will be held in 𝐒𝐚𝐧𝐭𝐢𝐚𝐠𝐨 𝐃𝐞 𝐂𝐨𝐦𝐩𝐨𝐬𝐭𝐞𝐥𝐚 a UNESCO World Heritage Site since 1985. Discover Santiago’s rich history and spiritual significance. To more info visit our webpage: 👉#places-not-to-be-missed" target="_blank" rel="nofollow noopener">iberianprion.org/2024/visitsant…

We are pleased to announce and host the 12th Iberian prion congress at the prestigious Universidad de Santiago - Galicia, on 23rd and 24th May 2024. For more info: 👉 iberianprion.org/2024/ #IberianPrion2024 #Santiagodecompostela #Scientificconference #prion

⁦Happy to share our latest paper. Great teamwork! @antonio_masone⁩ et al. A tetracationic porphyrin with dual anti-prion activity cell.com/iscience/fullt…

Today, it was an honor to host the ProFFIle project (proffile-prion.eu) meeting at @sunumsabanci in Istanbul, Turkiye. The meeting showcased promising developments in this international project funded by @JPNDeurope to identify biomarkers for FFI disease.

'Insonnia fatale familiare: al Mario Negri si cercano i biomarcatori spia sanitainformazione.it/salute/insonni…' proffile-prion.eu/ita/home-ita.h… @JPNDeurope @MarioNegriIRCCS @NeuroBesta @MustafaogluLab @CICbioGUNE @IIS_Bioaraba @afiffitalia @AIEnP3 @f_prionicas

in collaboration with other international research groups (Italy, Germany, Spain and Turkey), aims to identify biomarkers which could predict the onset of the disease and monitor if preventive treatments are effective.

Fatal familial insomnia is a rare genetic disorder belonging to the group of prion diseases, for which scientific research is studying potential therapies. The ProFFIle project, funded by the EU Joint Programme - Neurodegenerative Disease Research and coordinated by Mario Negri

Il progetto mira a identificare i biomarcatori, cioè delle spie in grado di predire l’insorgenza della malattia e monitorare l’effetto di trattamenti preventivi.

Il progetto è finanziato da @JPNDeurope e coordinato dal Mario Negri in collaborazione con gruppi di ricerca in Italia, Germania, Spagna e Turchia (@NeuroBesta, @sunumsabanci, @fenssabanci, @MustafaogluLab, @CICbioGUNE, @IIS_Bioaraba, @AIEnP3, @afiffitalia, @f_prionicas).